Jazz Pharmaceuticals
JAZZ
JAZZ
323 hedge funds and large institutions have $8.13B invested in Jazz Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 108 increasing their positions, 115 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
323
Holders Change
–
Holders Change %
0%
% of All Funds
7.41%
Holding in Top 10
11
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+83.33%
% of All Funds
0.25%
New
46
Increased
108
Reduced
115
Closed
41
Calls
$31.7M
Puts
$33.7M
Net Calls
-$2.02M
Net Calls Change
+$33.4M
Top Buyers
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$171M |
| 2 |
O
OrbiMed
New York
|
+$65.3M |
| 3 |
TCIM
TIAA CREF Investment Management
New York
|
+$39.2M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$34.1M |
| 5 |
Millennium Management
New York
|
+$29.2M |
